PubMed:32178765 / 1853-2054 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T14 0-201 Sentence denotes From Aug 28, 2017, to Aug 17, 2018, we screened 624 patients, of whom 381 were randomly assigned and treated with guselkumab every 4 weeks (n=128), guselkumab every 8 weeks (n=127), or placebo (n=126).
T14 0-201 Sentence denotes From Aug 28, 2017, to Aug 17, 2018, we screened 624 patients, of whom 381 were randomly assigned and treated with guselkumab every 4 weeks (n=128), guselkumab every 8 weeks (n=127), or placebo (n=126).

yaoziqian_800_3

Id Subject Object Predicate Lexical cue
T11 114-124 CI denotes guselkumab
T12 148-158 CI denotes guselkumab
T24 185-192 CI denotes placebo

Zierdiyeerkenaili_800_3

Id Subject Object Predicate Lexical cue
T12 114-124 CI denotes guselkumab
T13 148-158 CI denotes guselkumab
T21 185-192 CI denotes placebo